Latest News

EMA recommends first all-oral treatment to tackle deadly sleeping sickness

The European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive scientific opinion of fexinidazole, the first all-oral treatment that has been shown to be efficacious for both stages of sleeping sickness.

Source link

Related posts

Gut bacteria byproduct protects against Salmonella


STAT Plus: Pharmalittle: Surprise FDA approval may dampen storm over pricey drug; should the U.S. adopt reference pricing?


Medical News Today: Parkinson's: Modified protein works like a drug


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy